These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 28848930)
1. A Survey of Corticosteroid Dosing for Exacerbations of Chronic Obstructive Pulmonary Disease Requiring Assisted Ventilation. Kiser TH; Sevransky JE; Krishnan JA; Tonascia J; Wise RA; Checkley W; Walsh J; Sullivan JB; Wilson KC; Barker A; Moss M; Vandivier RW Chronic Obstr Pulm Dis; 2017 Jul; 4(3):186-193. PubMed ID: 28848930 [No Abstract] [Full Text] [Related]
2. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Walters JA; Tan DJ; White CJ; Gibson PG; Wood-Baker R; Walters EH Cochrane Database Syst Rev; 2014 Sep; 2014(9):CD001288. PubMed ID: 25178099 [TBL] [Abstract][Full Text] [Related]
3. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Walters JA; Tan DJ; White CJ; Wood-Baker R Cochrane Database Syst Rev; 2014 Dec; (12):CD006897. PubMed ID: 25491891 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support. Alía I; de la Cal MA; Esteban A; Abella A; Ferrer R; Molina FJ; Torres A; Gordo F; Elizalde JJ; de Pablo R; Huete A; Anzueto A Arch Intern Med; 2011 Nov; 171(21):1939-46. PubMed ID: 22123804 [TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exacerbation of chronic obstructive pulmonary disease. Ding Z; Li X; Lu Y; Rong G; Yang R; Zhang R; Wang G; Wei X; Ye Y; Qian Z; Liu H; Zhu D; Zhou R; Zhu K; Ni R; Xia K; Luo N; Pei C Respir Med; 2016 Dec; 121():39-47. PubMed ID: 27888990 [TBL] [Abstract][Full Text] [Related]
9. Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Exacerbations (SCCOPE): rationale and design of an equivalence trial. Veterans Administration Cooperative Trials SCCOPE Study Group. Erbland ML; Deupree RH; Niewoehner DE Control Clin Trials; 1998 Aug; 19(4):404-17. PubMed ID: 9683314 [TBL] [Abstract][Full Text] [Related]
10. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial). Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993 [TBL] [Abstract][Full Text] [Related]
11. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease. Kiser TH; Allen RR; Valuck RJ; Moss M; Vandivier RW Am J Respir Crit Care Med; 2014 May; 189(9):1052-64. PubMed ID: 24617842 [TBL] [Abstract][Full Text] [Related]
12. Systemic corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Schweiger TA; Zdanowicz M Am J Health Syst Pharm; 2010 Jul; 67(13):1061-9. PubMed ID: 20554591 [TBL] [Abstract][Full Text] [Related]
13. The Impact of Interprofessional Monitoring and Education on the Usage of Systemic Glucocorticoids in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Medication Use Review. Biondi NL; Samiratedu MM; Highsmith E; Rosenblum A; McGrady K; Knepper S; Bowers R Cureus; 2019 Nov; 11(11):e6224. PubMed ID: 31777703 [TBL] [Abstract][Full Text] [Related]
14. Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial. Leuppi JD; Schuetz P; Bingisser R; Bodmer M; Briel M; Drescher T; Duerring U; Henzen C; Leibbrandt Y; Maier S; Miedinger D; Müller B; Scherr A; Schindler C; Stoeckli R; Viatte S; von Garnier C; Tamm M; Rutishauser J JAMA; 2013 Jun; 309(21):2223-31. PubMed ID: 23695200 [TBL] [Abstract][Full Text] [Related]
15. Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease. Howcroft M; Walters EH; Wood-Baker R; Walters JA Cochrane Database Syst Rev; 2016 Dec; 12(12):CD005074. PubMed ID: 27990628 [TBL] [Abstract][Full Text] [Related]
16. A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol. Sivapalan P; Moberg M; Eklöf J; Janner J; Vestbo J; Laub RR; Browatzki A; Armbruster K; Wilcke JT; Seersholm N; Weinreich UM; Titlestad IL; Andreassen HF; Ulrik CS; Bødtger U; Nielsen TL; Hansen EF; Jensen JUS BMC Pulm Med; 2017 Aug; 17(1):114. PubMed ID: 28810909 [TBL] [Abstract][Full Text] [Related]
17. The use of a standardized order set reduces systemic corticosteroid dose and length of stay for individuals hospitalized with acute exacerbations of COPD: a cohort study. Gulati S; Zouk AN; Kalehoff JP; Wren CS; Davison PN; Kirkpatrick DP; Bhatt SP; Dransfield MT; Wells JM Int J Chron Obstruct Pulmon Dis; 2018; 13():2271-2278. PubMed ID: 30100717 [TBL] [Abstract][Full Text] [Related]
18. Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease? Vondracek SF; Hemstreet BA Pharmacotherapy; 2006 Apr; 26(4):522-32. PubMed ID: 16553512 [TBL] [Abstract][Full Text] [Related]
19. Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials. Cheng T; Gong Y; Guo Y; Cheng Q; Zhou M; Shi G; Wan H Clin Respir J; 2013 Oct; 7(4):305-18. PubMed ID: 23072733 [TBL] [Abstract][Full Text] [Related]